Immunotherapy for Dogs
Recent trials show that dogs with osteosarcoma receiving a new immunotherapy treatment experience a significant increase in survival rates, nearly doubling the typical twelve-month survival. While standard care offers only 35-40% survival, this innovative approach raises that figure to 60-65%, with some dogs living several years longer. For those interested, clinical trials are ongoing at multiple sites across the U.S. and Canada, providing hope for improved outcomes in canine cancer treatment.In this clip
From this podcast
Science Friday
It’s Hot. But How Hot? | Canine Cancer Vaccine Shows Promising Results
Related Questions